CLASS II ONGOING Device recall · Reported 4 Jun 2025 · FDA Enforcement Report

BioFire Respiratory Panel 1 plus Kit recalled by BioFire Diagnostics

BioFire Diagnostics is recalling BioFire Respiratory Panel 1 plus Kit, distributed nationwide in the US. The recall was initiated on 30 Apr 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot# 1475424/ UDI: None
Quantity recalled30 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1877-2025
FDA event ID
96835
Recalling firm
BioFire Diagnostics, Salt Lake City, UT
Classification
Class II
Status
Ongoing
Recall initiated
30 Apr 2025
FDA classified
29 May 2025
Reported
4 Jun 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

30 Apr 2025Recall initiated by company
29 May 2025Classified by FDA+29 days
4 Jun 2025Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to manufacturing error, respiratory panel may result in elevated control failures and/or false negative results.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

BioFire Respiratory Panel 2.1 plus Kit, REF: 423740, For Filmarray systems

Where it was distributed

International distribution in the country of Singapore.

Nationwide

Questions about this recall

Is BioFire Respiratory Panel 1 plus Kit recalled?

Yes. BioFire Diagnostics recalled BioFire Respiratory Panel 1 plus Kit on 30 Apr 2025. The recall is Class II and its status is Ongoing. Recall number Z-1877-2025.

Why was it recalled?

Due to manufacturing error, respiratory panel may result in elevated control failures and/or false negative results.

Which lots are affected?

Lot# 1475424/ UDI: None

Where was it sold?

International distribution in the country of Singapore.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from BioFire Diagnostics

All 44

Other CPAP & Ventilators recalls

All 551